Active

Camba-Pharma

Switched

BE0717740414

Rechtspersoon Private limited company 1 establishment

Droogveldeweg 7, 9031 Gent Detailhandel in farmaceutische producten

Active for

7 year, 8 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 69,398

▲ 22% vs 2024

Profit

Growing

€ 47,651

▲ 29% vs 2024

Debts

Normal

€ 300,724

▼ 15% vs 2024

Camba-Pharma from Gent, company number BE0717740414, closed financial year 2025 with a result of € 47,651 after tax. For that financial year Camba-Pharma recorded a gross margin of € 69,398 and equity of € 137,100. Compared with financial year 2024, the result moved from € 36,955 to € 47,651. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 8, 2026.

What happened at Camba-Pharma?

What happened at Camba-Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 47,651 (▲ 29% vs 2024). Source: NBB ↗
  • New establishment in Gent. KBO
  • Camille Baetslé became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 20,240 profit in 2021 to € 47,651 profit in 2025.

Paid € 65,643 in corporate taxes since 2021.

Best year ever: 2025, with € 47,651 profit.

Paid out € 71,233 in dividends to the owners in total.

A new publication or filing at Camba-Pharma? We notify you, reason included.

Follow Camba-Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Camille Baetslé
Camba-Pharma
Bioclin 50%

Behind Camba-Pharma is Camille Baetslé. It owns 50% of Bioclin itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Camille Baetslé

Director

Also active at: BIOCLIN

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Droogveldeweg 7

9031 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0717.740.414
VAT number
BE 0717.740.414
Registered office
Droogveldeweg 7, 9031 Gent
Names & denominations
Camba-Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
7 January 2019
Peppol
Active · Active since 24 Nov 2023
Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of Camba-Pharma?
The enterprise number of Camba-Pharma is BE0717740414.
What is the address of Camba-Pharma?
The registered office of Camba-Pharma is located at Droogveldeweg 7, 9031 Gent.
When was Camba-Pharma founded?
Camba-Pharma was founded on 7 January 2019.
What is the main activity of Camba-Pharma?
The main activity of Camba-Pharma is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does Camba-Pharma have a website?
No website is currently known for Camba-Pharma.
How much profit did Camba-Pharma make in 2025?
Camba-Pharma posted a profit after taxes of € 47,651 in financial year 2025.
What is the revenue of Camba-Pharma?
As a small company, Camba-Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 69,398.
Where can I find the annual accounts of Camba-Pharma?
Camba-Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Camba-Pharma?
According to the 2025 annual accounts, the directors of Camba-Pharma are: Camille Baetslé.
Who owns Camba-Pharma?
Behind Camba-Pharma is Camille Baetslé. It owns 50% of Bioclin itself.